CANNASOUL GROUP

📍 Ceasarea, Israel🗓 Founded 2018👥 17 employees💰 Last funded Jan 2019
Cannasoul is Israel’s leading analytical service provider. Utilizing its proprietary know-how and expertise, Cannasoul has become a top-tier expert in the field of analytical method development for pharma and botanical R&D providing the necessary and crucial information to meet the standards for the development of effective, safe, and reliable products, treatments, and pharmaceuticals. Cannasoul also holds a unique expertise in the field of Cannabis and Psilocybin research and is the first company in the world to analyze over 100 cannabinoids and 100 terpenes. In addition to the comprehensive phytocannabinoid and terpene analysis, Cannasoul offers a unique and comprehensive endocannabinoid analysis in a wide range of matrixes. Cannasoul is a scientific partner to leading research organizations and pharmaceutical companies and supports them with R&D activities, pre-clinical and clinical trials, including pharmacokinetic studies (PK) and other bio-analytics.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in CANNASOUL GROUP?
CANNASOUL GROUP has 1 investors on record on gritt.io, including 1 early-stage backers.
When did CANNASOUL GROUP last raise funding?
The most recent investment in CANNASOUL GROUP recorded on gritt.io was in January 2019.
When was CANNASOUL GROUP founded?
CANNASOUL GROUP was founded in 2018.
What industry is CANNASOUL GROUP in?
CANNASOUL GROUP operates in Research Services. Find similar Research Services investors on gritt.io.
Where is CANNASOUL GROUP based?
CANNASOUL GROUP is headquartered in Ceasarea, Israel.